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Objective: To explore the persistency of Medically Unexplained Symptoms (MUS) and
its prognostic factors in the general adult population. Knowledge of prognostic factors
of MUS may indicate possible avenues for intervention development.
Methods: Data were derived from the Netherlands Mental Health Survey and Incidence
Study-2 (NEMESIS-2), a nationally representative face-to-face cohort study among the
Dutch general population aged 18–64 years. We selected subjects with MUS at baseline
and who participated at follow-up (N = 324) and reassessed those subjects for having
MUS at 3 year follow-up. Logistic regression analyses were used to determine risk factors
for persistency of MUS.
Results: 36.4% of the subjects had persistent MUS at follow-up. In logistic regression
analyses adjusted for sex and age, persistency of MUS was predicted by the number of
comorbid chronic medical disorder(s), lower education, female sex, not having a paid job,
parental psychopathology as well as lower functioning. In the logistic regression analysis
in which all significant variables adjusted for sex and age were entered simultaneously,
three variables predicted persistent MUS: parental psychopathology, the number of
comorbid chronic medical disorder(s) and physical functioning, with odds ratios of 2.01
(1.20–3.38), 1.19 (1.01–1.40), and 0.99 (0.97–1.00), respectively.
Conclusion: In the adult general population, MUS were persistent in over one
third of the subjects with MUS at baseline. Persistency was significantly predicted by
parental psychopathology, number of comorbid chronic medical disorders, and physical
functioning. These findings warrant further research into early intervention and treatment
options for persons with an increased risk of persistent MUS.
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INTRODUCTION
Background
Persons with Medically Unexplained physical Symptoms (MUS)
are highly prevalent in health care settings (1), and in the general
population (2, 3). MUS can be defined as physical symptoms
for which a physician cannot find a sufficient explanation after
proper medical examination (4–6). Persistent MUS can be
severe and disabling (7–11), and lead to high health care use
(12) and high costs (13). Persons with persistent MUS can be
tempted to seek treatments that are not supported by scientific
evidence(14). A specific focus on MUS is important, because
treatment plans for MUS usually differ from treatment plans for
chronic medical conditions. For physical symptoms explained by
a chronic medical disorder, guidelines for a multitude of chronic
medical disorders exist and can be used. For MUS, guidelines
for treatment of MUS can be used (6, 15). Therefore, it is
important to gain insight in predictors of persistent MUS, so that
in an early stage persons with a high risk of having persistent
MUS can get adequate treatment, such as collaboration with or
referral to a physiotherapist or psychologist. We know little about
the prognosis of persons with MUS in the general population
and its determinants, as previous longitudinal research was
mainly performed in selected groups, namely hospital or primary
care patients. More precise estimates of how many persons
with MUS -i.e., in the general population- suffer persistently
from MUS, and what factors influence this persistency facilitate
resource and care planning and may indicate possible avenues
for future intervention development. This is needed, because
such interventions can perhaps lead to a more favorable course
of MUS and thereby reduce the heavy burden and impairment
persons with persistent MUS can experience and they can help to
possibly reduce costs.
Among patients with MUS in a general medical outpatient
clinic, respectively 29 and 24% of the patients still had MUS at
11.6 and 15.2 months follow-up (16, 17). In another study in a
general medical outpatient clinic with a mean follow-up of 61
weeks, 38% of the patients reported that their symptoms persisted
(18). Among patients with MUS in a neurology outpatient clinic
with 8 months follow-up, as much as 54% of the MUS persisted
(19). Persistence of MUS was predicted by a longer duration of
the MUS at baseline (18), higher number of (either explained or
unexplained) physical symptoms at baseline (17, 18), and female
sex (17).
In primary care, 51.2% of the MUS at baseline persisted
during the course of 1 year (1). In over half of these patients
the main MUS was pain. Significant predictors for persistent
MUS after 1 year among these primary care patients with MUS
were: negative life events, autonomic sensations (the experience
of bodily symptoms), and the attribution of MUS to somatic
disease -rather than psychological factors- by the patient (1).
In another primary care study, 56.8% of the MUS persisted
over a 2 year follow-up, with symptoms in multiple organs
being a predictor of persistency (20). Another study found
negative affect -which is closely associated with depression- to
be an important determinant of persistent MUS, most probably
because it contributes to symptom evolution as well as symptom
severity, whereas positive affect has a beneficial effect on somatic
symptom evolution (21). A systematic review concludes that
because of a lack of rigorous empirical evidence, more research is
needed to identify relevant prognostic factors for persistent MUS
(10), as these are needed to develop effective interventions.
In the general population, even less is known about the course
of MUS in adults. Research mainly focused on adolescents; it is
not clear that MUS in adolescents and in adults are the same
phenomenon (22). Possibly, higher percentages of persistency
can be found in selected secondary or primary care patient groups
with MUS compared to in the general population, because the
former groups would be the more severe and chronic cases of
MUS. Persistent MUS was found in only 4.1% of community
adolescents with MUS at baseline (mean age 11.1 years) over
a period of 5 years (mean age at reassessment 16.3 years)
(23). In these adolescents, risk factors measured at baseline
of the study for persistent MUS were female sex, presence of
depressive symptoms, poor self-rated health, and parents‘report
of a high number of MUS among their adolescent child (23). In
another study it was found that subjects who score high (above
the 90th percentile of the total score) on various symptoms,
MUS tend to persist more often from childhood to adulthood
when compared to low-scoring subjects (24). Perfectionism was
also found to be associated with the persistence of MUS, this
effect was significantly mediated by symptoms of anxiety and
depression (25). Childhood adversities such as abuse and neglect
increased the risk of diverse chronic physical conditions in later
life (26); possibly this is also the case for MUS. In a study
focusing on non-referred adolescents with somatoform disorder,
35.9% still met this diagnosis 15 months later (27). Predictors
of persistency were female sex, comorbid depressive disorder,
parental psychopathology, and number of negative life events.
To our knowledge, only the persistency and predictors of
persistent medically unexplained pain symptoms (MUS-pain)
have been studied in the adult general population (28). One
third (33.6%) of MUS-pain was persistent, when measured over
an 11 years interval. From the possible predictors measured at
baseline, only female sex was a risk factor for persistence of
MUS-pain. These results on MUS-pain cannot be generalized to
all MUS, because MUS such as dizziness, overtiredness, nausea,
and irritable bowel syndrome could have different risk factors
for persistence compared to pain. If those risk factors can be
influenced or treated, this is important information for the
development of interventions. From a clinical perspective, a
shorter follow-up course of a few years may be more relevant
than a much longer period of time, and will possibly result in
more risk-indicators than were found in the study of Leiknes and
colleagues who only focused on MUS-pain over a period of 11
years (28).
The aim of this study is to estimate the persistence ofMUS and
explore prognostic factors among the adult general population.
Prognostic factors can be categorized as demographic variables,
vulnerability (e.g., trauma, negative life events), comorbid
mental, and physical disorders, and mental and physical
functioning. This study will add to the body of literature, given
that the previous literature mainly focused on selected groups,
i.e., patients seen by doctors [in primary care (1, 10, 21) or
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clinical setting (16–19)]. These selected patient groups comprise
especially those persons with MUS with a high burden of MUS
(29), and high costs (13). Insight in the course of MUS and its
predicting factors in the general population is important, because
it will tell us which MUS have a high risk of becoming persistent.
Objective
Our objective is to estimate the persistency of MUS and to
determine what factors influence this persistency in the adult
general population. Based on previous findings, we hypothesize
that female sex, childhood trauma, parental psychopathology,
presence of negative life events, presence of common mental
disorders, number of comorbid chronic medical disorder(s), and
worse physical or general functioning–all measured at baseline-
are associated with persistence of MUS measured at 3-year
follow-up.
METHODS
Study Design
In this general population study, we examine the persistency
of MUS and what factors are associated with persistence of
MUS, over 3 years. We report our findings according to
the STrengthening the Reporting of OBservational studies in
Epidemiology (STROBE) statement (30).
Setting and Participants
Data were derived from the Netherlands Mental Health Survey
and Incidence Study-2 (NEMESIS-2). Methods of NEMESIS-2
are described in details elsewhere (31, 32). Here, we give a short
description, which has been published earlier (33). NEMESIS-
2 was approved by a medical ethic Committee (METIGG).
After being informed about the study, subjects provided written
informed consent. For this paper, data were used from the first
wave (T0), performed from November 2007 to July 2009, and the
second wave (T1), performed from November 2010 to June 2012.
NEMESIS-2 is based on a multistage, stratified random
sampling of households, with one respondent aged 18–64
years randomly selected in each household for a face-to-
face interview. The interviews were conducted by professional,
experienced interviewers. The response rate was 65.1%. The
sample was nationally representative, except younger subjects
were somewhat underrepresented. Of the 6646 baseline subjects,
140 subjects received a shortened version of the questionnaire,
and as a consequence they did not receive questions about
somatic disorders. Therefore, the number of subjects available
at T0 was 6506 of which 386 subjects had MUS at T0. Of
those 386, data were available of 324 subjects at T1. Those 324
subjects comprised our study cohort. They were assessed at
T0 for the possible predicting factors for persistency of MUS,
and reassessed for having MUS at T1. The attrition rate at 3
year follow-up for the 6,646 baseline subjects was 20.2%. The
presence of psychopathology in the past 12 months at baseline
was not significantly associated with attrition, after controlling
for sociodemographic characteristics (34). The attrition rate for
the 386 subjects with MUS at T0 was 16.1%; none of the variables
presented in Table 2 that were measured at T0 were statistically
significant associated with this attrition. Also having MUS at T0
was not statistically significantly associated with attrition at T1.
Variables
We use the following definition of MUS (33): presence of one
or more physical symptom(s) in the past 12 months for which
no adequate organ pathology or pathophysiological basis was
found, and for which, according to the subject, a physician was
consulted and/or medication was received, and which caused
discomfort and functional impairment in the past 4 weeks as
measured by the Short Form 36 (SF-36) (35). In line with the
Somatic Symptom Disorder (SSD) definition in the Diagnostic
and Statistical Manual of Mental Disorders, fifth edition (DSM-
5) (36), we included the presence of discomfort and functional
impairment in our definition. Persistence of MUS is defined as
presence of MUS at both T0 and T1.
Data Sources/Measurement
The measuring instruments for MUS and the possible predictors
of persistent MUS are described in Table 1 [partially published
in our previous studies (33, 53)]. Table 1 is available as an online
addendum.
Bias
All definitions inTable 1were predefined, and as strict as possible
defined to support unambiguous interpretation. Definitions
are in line with previously published papers using data from
NEMESIS-2 (33, 53). Given that the data had already been
collected by independent researchers, results could not be
influenced by the authors. There were nomissing data for most of
the possible predictors of persistence at baseline. Only household
income had 21 missings (6.5%) and the role-emotional scale of
the SF-36 had one missing (0.3%).
Quantitative Variables and Study Size
Three hundred and twenty four subjects of the 386 subjects
with MUS at T0 could be reassessment at T1. Those 324 were
reassessed for havingMUS at 3-year follow-up, and were assessed
for the possible prediction factors for the persistency of MUS as
described in Table 1.
Statistical Methods
All analyses were performed using STATA version 12.1. Given
the relatively small group of subjects with MUS (i.e., 324
respondents), unweighted data were used. In order to describe
the percentage that persisted in having MUS at follow-up, we
performed a cross-tabulation of MUS-cases at T1. In order to
define what risk factors at baseline influence persistency of MUS
at follow-up (yes/no), we performed logistic regression analyses
adjusted for sex and age (Table 2: model 1). In the next step,
all significant variables adjusted for sex and age from model 1
were entered simultaneously in one more fully adjusted logistic
regression analysis (Table 2: model 2), to find unconfounded
estimates of risk factors for persistency. To test for linear trends,
potential determinants (i.e., age, education level, and household
income) were also modeled separately as continuous variables (P
for trend test).
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TABLE 1 | Variables: definitions and measurement instruments (online addendum).
Measurement Measuring instrument
MEDICALLY UNEXPLAINED PHYSICAL SYMPTOMS
Subjects were considered to have MUS if their condition applied to both
criteria mentioned below:
Face-to-face interview based on a questionnaire of physical symptoms, in which
the main physical symptoms and chronic medical conditions of the CBS
(Statistics Netherlands) questionnaire can be found.(37) These physical
symptoms were based on self-report by the subjects during the interview, (38)
and they had to specify if they sought medical treatment for that. Only in that
case they were taken into account.
1. Presence of one of the following physical symptoms, experienced in the
past 12 months, for which the subjects indicated that they visited a
physician and/or received medication:
a) Disturbing intestinal symptoms, existing longer than 3 months, for which
no indication of an explanation existed (39–41).
b) Back problems existing longer than 3 months, for which no indication of
an explanation existed (40, 42).
c) Other illness or physical symptoms that are long lasting (open question)
and unexplained
All physical symptoms mentioned here (verbatim responses) were checked
independently by two physicians (JES and CFC) to indicate whether or not they
could be considered medically unexplained physical symptoms in general. If their
judgments were not the same, they deliberated until consensus was achieved.
We checked the answers on the open questions to see if an explanation was
given about the intestinal symptoms, such as pancreatitis or hernia abdominalis,
or the back problem, such as neck hernia or paraplegia. If this was the case, we
did not include the subject in the unexplained group, but in the explained group.
Examples of general symptoms that we considered to be medically unexplained
physical symptoms are fibromyalgia, fatigue (such as chronic fatigue syndrome),
pain without medical explanation (such as stress related pain in muscles), and
physical symptoms accompanied with phrases such as “they can’t find
anything” or “if only I knew”.
2. Presence of limited functioning reported in the past 4 weeks, as indicated
by two or more of the physical health subscales of the SF-36 (35, 43).
Interview based on the SF-36 physical health subscales:
a) Physical functioning: some or severe limitations in at least one of the 10 items
in this category
b) Physical role functioning: any limitation reported in at least one of the four
items in this category
c) Bodily pain: pain leading to any limitation in normal work activities
d) General health: describes mental or physical health as poor, and/or negative
expectations about one’s health.
Possible predicting factors of persistence of MUS Face-to-face interview
Sex Male/female
Partner status Living with or without partner
Age Based on the date of birth, divided in four age groups: a) 18–34 year
b) 35–44 year
c) 45–54 year
d) 55–64 year
age groups 18–24 years and 25–34 years were put together because of the
small number of respondents per group; respectively n = 7 and n = 34.
Employment situation Describes whether the subject has a paid job. Not only the main work situation
was taken into account, but also any other type of work situations (e.g., a
student who also has a payed employment, will be counted as having a paid job).
Education Self-report:
a) Primary, basic vocational or lower secondary
b) Higher secondary
c) Higher professional, University
Household income Self-report: classification in based on the average income in the Netherlands in
2007 (€1,500 net income per month)
a) Low: <average; ≤1,500 euro net per month
b) Middle: 1 to 2 times average; 1,501–3,300 euro net per month
c) High: more than 2 times average; >3,300 euro net per month
Childhood trauma before age 16 Self-report of emotional neglect (not listened to, ignored or unsupported),
psychological abuse (yelled at, insulted, unjustly punished/treated, threatened,
belittled, or blackmailed), physical abuse (kicked, hit, bitten or hurt with object or
hot water), or sexual abuse (any unwanted sexual experience) before age 16.
Emotional, psychological, or physical abuse was scored present if the
respondent reported this had occurred more than once. Sexual abuse was also
scored present if the respondent reported this had occurred once.
Parental psychopathology: Lifetime mental problems parents. These questions were asked at T1.
Negative life events The presence of 10 negative life events in the past 12 months, based on the
“Brugha Life events section” (44)
(Continued)
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TABLE 1 | Continued
Measurement Measuring instrument
Comorbid chronic medical disorder(s):
Respiratory disorders (asthma, chronic obstructive pulmonary disease,
chronic bronchitis, emphysema), cardiovascular disorders (severe heart
disease, heart attack, hypertension, stroke), stomach or intestinal ulcers,
severe intestinal symptoms (only if an explanation about the cause was
given such as pancreatitis, hernia abdominalis), diabetes, thyroid disorder,
chronic back pain (only if an explanation about the cause was given such as
neck hernia, paraplegia, caused by accident), arthritis, migraine, cancer,
impaired vision or hearing.
Interview based on questionnaire of physical symptoms, in which the main
physical symptoms of the CBS (Statistics Netherlands) questionnaire can be
found.(37) These physical symptoms were based on self-report by the subjects
during the interview, and not by medical records (38). Comparisons between
self-reports of chronic physical disorders and medical records show moderate to
good concordance (45–47). Subjects were considered to have comorbid chronic
medical disorder(s) if they reported to have been treated or monitored by a
physician in the prior 12 months for one or more of the disorders, and after
confirmation by two physicians (JES and CFC), in duplicate, that symptoms
should be considered to be medically explained. The number of comorbid
chronic medical disorders was counted.
DSM-IV mental disorders:
DSM-IV mood disorder (major depression, dysthymia, bipolar disorder),
anxiety disorder (panic disorder, agoraphobia (without panic disorder), social
phobia, specific phobia, generalized anxiety disorder), and substance use
disorder (alcohol/drug abuse and dependence). Here we combined the
12-month mood, anxiety, and substance use disorders, to form the group
“any 12-month mental disorder”.
Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) (38, 48, 49):
The interviews were conducted by professional, experienced interviewers.
Clinical calibration studies conducted in various countries have found that CIDI
3.0 (50) and earlier versions (51, 52) assess anxiety, mood and substance use
disorders with generally good validity compared to blinded clinical reappraisal
interviews.
Functioning
a) Social role functioning
b) Emotional role functioning
c) Mental health
d) Vitality
e) Bodily pain
f) Physical functioning
g) Physical role functioning
h) General health perceptions
Score (0–100) -low to high functioning- on the SF-36 sections:
a) Social functioning scale
b) Role-emotional scale
c) Mental health scale
d) Vitality scale
e) Bodily pain
f) Physical functioning
g) Role-physical scale
h) General health
RESULTS
Outcome Data and Main Results
Of the 324 subjects with MUS at baseline, 118 (36.4%) had
persistent MUS, meaning they had MUS at both T0 and T1.
Table 2 (model 1) shows that, in subjects with MUS at baseline,
having persistent MUS is statistically significant predicted by
female sex (OR 1.79; 95%CI 1.08–2.97), not having a paid job
(OR 1.65; 95%CI 1.01–2.69), lower education (OR 1.89; 95%CI
1.03–3.48), parental psychopathology (1.71; 95%CI 1.05–2.78)
and number of comorbid chronic medical disorder(s) (OR 1.22;
95%CI 1.05–1.42). A lower odds of having persistent MUS, is
statistically significantly predicted by a higher score (meaning
better functioning) on four scales of the SF-36. Those scales
comprised social functioning (OR 0.99; 95%CI 0.98–10.00),
bodily pain (0.98; 95%CI 0.97–0.99), physical functioning (0.98;
95%CI 0.97–0.99) and general health (0.98, 95%CI 0.97–0.99).
The SF-36 subscales range from 0 to 100, the ORs refer to a
1-point increase of the subscales. The other variables shown
in Table 2 did not statistically significantly predict persistency
of MUS. Besides any 12-month mental disorder, persistency of
MUS was also not statistically significant predicted by any 12-
month mood disorder (OR 1.13; 95%CI 0.36–2.28) and any
12-month anxiety disorder (OR1.30; 95%CI 0.73–2.31) (not
shown in table). Besides any childhood trauma before age
16, the subcategories (emotional neglect, psychological abuse,
physical abuse, and sexual abuse) also did not statistically
significant predicted persistence of MUS (not shown in
table).
For the variables that were subdivided in three or more
categories (age, education level, and household income) a p
for trend was calculated. No statistically significant association
was found with increasing age, education level, and household
income and odds of having persistent MUS (see Table 2).
Multivariate Analyses
A multivariate analysis was performed with the statistically
significant findings (p < 0.05) from the analyses adjusted for sex
and age. Of those, parental psychopathology (OR 2.01; 95%CI
1.20–3.38), number of comorbid chronic medical disorder(s)
(OR 1.19; 95%CI 1.01–1.40) and the physical functioning scale
of the SF-36 (OR 0.99; 95%CI 0.97–1.00) remained statistically
significant predictors for having persistent MUS after 3 years.
Female sex, not having a paid job, education level and social
functioning, bodily pain and general health did not statistically
significantly predict persistency of MUS anymore (Table 2;
model 2).
DISCUSSION
Key Results and Interpretation
To our knowledge, this study is among the first to explore
the persistency of MUS in the adult general population.
The findings are that over a 3-year follow-up, 36.4% of
our sample with MUS at baseline had persistent MUS.
Persistency of MUS is predicted by number of comorbid chronic
medical disorder(s), lower education, female sex, parental
psychopathology, and not having a paid job; in the logistic
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TABLE 2 | Predictors of persistence of MUS (N = 324).
% OR (95%CI)
Model 1
OR (95%CI)
Model 2
DEMOGRAPHIC VARIABLES
SEX
Female 66.7 1.79 (1.08–2.97)* 1.23 (0.71,2.12)
PARTNER STATUS
No partner 34.3 0.75 (0.46–1.23)
AGE
18–34 13.3 1
35–44 21.6 1.26 (0.54–2.93)
45–54 30.2 2.04 (0.93–4.48)
55–64 34.9 1.81 (0.83–3.94)
p for trend 0.084
EMPLOYMENT SITUATION
No paid job 42.3 1.65 (1.01–2.69)* 1.07 (0.63,1.82)
EDUCATION
Primary, basic vocational or lower secondary 42.0 1.89 (1.03–3.48)* 1.80 (0.93,3.47)
Higher secondary 31.8 1.80 (0.95–3.41) 1.94 (0.99,3.81)
Higher professional or university 26.2 1 1
p for trend 0.053
HOUSEHOLD INCOME
Low 32.4 1
Middle 50.8 0.70 (0.41–1.19)
High 16.8 0.55 (0.26–1.16)
p for trend 0.088
VULNERABILITY
Any childhood trauma before age 16 41.1 1.24 (0.77–1.99)
Parental psychopathology: lifetime mental problems parents at T1 38.3 1.71 (1.05–2.78)* 2.01 (1.20,3.38)*
Any negative life event in the 12 months before baseline 66.1 0.74 (0.45–1.19)
COMORBID PHYSICAL AND MENTAL DISORDERS
Number of comorbid chronic medical disorder(s) Mean (se) 1.55 (0.09) 1.22 (1.05–1.42)* 1.19 (1.01,1.40)*
Any 12-month common mental disorder at baseline 28.7 1.47 (0.89–2.43)
Mental and physical functioning (scale 0–100) Mean (se)
Social role functioning 76.0 (1.44) 0.99 (0.98–1.00)* 1.00 (0.99,1.01)
Emotional role functioning 85.3 (1.80) 1.00 (0.99–1.01)
Mental health 78.7 (0.90) 1.00 (0.98–1.01)
Vitality 58.0 (1.11) 0.99 (0.98–1.00)
Bodily pain 54.1 (1.29) 0.98 (0.97–0.99)* 0.99 (0.98,1.00)
Physical functioning 66.9 (1.27) 0.98 (0.97–0.99)* 0.99 (0.97,1.00)*
Physical role functioning 44.3 (2.33) 0.99 (0.99–1.00)
General health perceptions 50.1 (1.09) 0.98 (0.97–0.99)* 0.99 (0.98,1.01)
Odds ratio (OR) with 95% Confidence Interval (CI) or mean with standard error (se), adjusted for sex and age (model 1), or adjusted for all variables in this column (model 2).
Model 1: adjusted for sex and age.
Model 2: adjusted for all variables in this column.
*p < 0.05.
regression analysis adjusted for sex and age. A lower odds
of having persistent MUS is predicted by better functioning
as measured with the SF-36 in the areas social functioning,
bodily pain, physical functioning, and general health. Our
hypothesis about which variables predict persistency of MUS
is confirmed -in the logistic regression analyses adjusted for
sex and age (Table 2: model 1)-for number of comorbid
chronic medical disorder(s), female sex, and partly for mental
and physical functioning. These findings are in line with
previous studies (16–19, 23, 54). An association between worse
physical functioning at baseline measured with the SF-36 and
persistent MUS at follow-up was found before in neurology
patients (19). A possible explanation for the other variables
that predicted persistency of MUS -namely lower education,
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parental psychopathology, and not having a paid job- is that
they can have a negative influence on overall functioning and
well-being (55–58).
Parental psychopathology had the highest OR in the
multivariate logistic regression model, followed by number of
comorbid chronic medical disorder(s). Also, better physical
functioning measured by the SF-36 predicted persistent MUS
statistically significant in this model. The other predictors
found in the logistic regression analyses adjusted for sex and
age (model 1) were not statistically significant in the more
fully adjusted logistic regression analysis (model 2). Previous
research showed an association between both paternal and
maternal depression and increased risk of psychopathology in
their offspring (59–61). Apparently, parental psychopathology
is an indicator for vulnerability, which is also expressed in the
increased risk of persistent MUS. This is in line with previous
research about somatoform disorder in adolescents (27). The
number of comorbid chronic medical disorder(s) as a predictor
for persistence of MUS is in line with previous research (17,
18). A higher number of physical symptoms is also associated
with a higher number of medical consultations (62). A possible
explanation is, that it is more difficult to adequately cope with
physical symptoms when they are partly MUS and partly due to a
chronic medical disorder. A higher number of medical disorders
only adds to this complexity (63).
In the less and more fully adjusted logistic regression analyses
(model 1 and model 2), no statistically significant ORs were
found for partner status, age, household income, any childhood
trauma before age 16, any 12 months negative life event, any 12
month common mental disorder, and lower levels of functioning
measured with the SF-36 in the subscales emotional role
functioning, mental health, vitality and physical role functioning
at baseline. This means our hypothesis about what variables
predict persistency of MUS is not confirmed for childhood
trauma, presence of negative life events, and presence of common
mental disorders. Childhood adversities increase the risk of
diverse chronic physical conditions -such as hypertension, heart
disease and asthma- later in life (26, 64). Childhood adversities
are also associated with the onset of mental disorders later in
life (65), and childhood sexual abuse was found to be associated
with MUS as well as chronic pelvic pain in previous research
(66, 67). We have no explanation for the fact that we did not
find similar results with regard to the persistency of MUS. We
can hypothesize, however, that this finding indicates a difference
between persistent MUS in the general population and the
clinical setting. Perhaps childhood adversities are associated with
more severe MUS or with help-seeking, which could explain
the correlation between childhood adversities and MUS is more
common in clinical settings compared to this general population
research. Further research exploring the association between
childhood adverse events and (explained or unexplained)
physical symptoms is therefore warranted, taken into account
the severity of the MUS and help-seeking behavior. MUS are
associated with higher odds of having common mental disorders
(33), but in this study we did not find a higher odds of having
persistent MUS when common mental disorders were present at
baseline.
Research performed in general hospital and in primary care
showed persistency rates of 24–54% (1, 16–19), with follow-up
times varying from 8 to 15 months. In the general population,
persistence MUS was found in 33.6% of MUS-pain, with an 11
year follow-up (28). The percentage of persistency we found in
this study, 36.4%, does not differ largely from the persistency
rates found in the majority of the beforementioned studies.
However, the follow-up period varies between the studies, which
makes it difficult to compare these persistency rates. We expected
higher persistency rates when follow up periods are shorter, but
when we compare these studies, there is no clear relation between
length of follow-up and persistency rate.
LIMITATIONS
We used an existing longitudinal epidemiological database that
was aimed at assessing mental disorders. This database also
contains information about physical symptoms and possible
predictors of mental disorders. For the current study, we were
therefore limited to the available data. The information given
by the respondents was used to determine whether or not the
physical symptoms could be considered MUS. For this purpose,
all physical symptoms mentioned were checked independently
in duplicate by two physicians (JES and CFC). We did not have
access to the medical records of the respondents. Comparisons
between chronic medical conditions and symptoms as assessed
by medical records show moderate to good concordance (46,
68–70) Currently, the focus is more on the way patients cope
emotionally, cognitively and behaviorally with their physical
symptoms, then whether they are explained or not (36). We
included the presence of discomfort and functional impairment
in our definition of MUS, in order to approach the criteria of
the Somatic Symptom Disorder as described in the DSM 5 (36).
Although we used an existing database, we believe our methods
of operationalization and classification are reasonable for MUS.
We only classified symptoms that led to treatment seeking as
MUS, because this is an indication that the complaints are not
quickly passing symptoms that are not severe enough to be
considered MUS (as in line with our definition). The definition
of MUS is based on the older concept of somatization (71).
Somatization is defined by Lipowski as “a tendency to experience
and communicate somatic distress in response to psychosocial
stress and to seekmedical help for it” (72). Seeking treatment is an
essential part of the definition somatisation andMUS (72–74), so
in our article we stay in line with this. It should be noted however,
that the definition of MUS remains subject of debate (75, 76).
A limitation of the current study is that we do not know
the onset date of the MUS, we only know whether or not the
MUS were present at T0, but and not for how long already. Due
to the limited available variables, we were not able to explore
health anxiety and avoidance behavior. The power of different
predictor variables can also differ because of statistical features of
the variable (e.g., binary vs. continuous variables and reliability
of assessments). It is also possible that limited power has led to
non-significant correlations inmodel 2, whichmeans larger study
samples are needed to reassess this.
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Generalizability
NEMESIS-2 is a large, nationally representative sample of the
adult Dutch general population. Therefore, the results of this
study can be extrapolated to the general population of the
Netherlands, and possibly to more countries. We did not assess
the onset date of the MUS, therefore the MUS at baseline will
be a mixture of first-onset symptoms and chronic symptoms.
This limits the generalizability to unselected groups of persons
with MUS, given that the role of predictor variables can vary
between groups with first-onset symptoms and groups with
chronic symptoms.
CONCLUSION
In this general population study, MUS are persistent in 36.4%
measured over a 3-year interval. Persistency is significantly
predicted by parental psychopathology and having comorbid
chronic medical disorder(s). The parental psychopathology is an
interesting subject for further research, given that it can possibly
lead to early interventions and specific treatment options. For
example, when the stepped care approach as described in the
Dutch guideline for treatment of MUS (6) is used, collaboration
with or referral to a physiotherapist or psychologist could be
recommended in an early stage for persons with a high risk of
having persistent MUS.
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